Tang Capital Management as of Dec. 31, 2023
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 123 positions in its portfolio as reported in the December 2023 quarterly 13F filing
Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
---|---|---|---|---|---|
Mirati Therapeutics | 8.5 | $92M | 1.6M | 58.75 | |
ImmunoGen | 6.0 | $65M | 2.2M | 29.65 | |
Tarsus Pharmaceuticals (TARS) | 4.1 | $45M | 2.2M | 20.25 | |
Kalvista Pharmaceuticals (KALV) | 3.9 | $42M | 3.4M | 12.25 | |
Lianbio Sponsored Ads (LIANY) | 3.9 | $42M | 9.4M | 4.47 | |
Anaptysbio Inc Common (ANAB) | 3.9 | $42M | 2.0M | 21.42 | |
Mirum Pharmaceuticals (MIRM) | 3.1 | $34M | 1.1M | 29.52 | |
Evolus (EOLS) | 3.0 | $33M | 3.1M | 10.53 | |
Altimmune Com New (ALT) | 2.9 | $31M | 2.8M | 11.25 | |
Immunocore Hldgs Ads (IMCR) | 2.6 | $28M | 406k | 68.32 | |
Axsome Therapeutics (AXSM) | 2.4 | $26M | 320k | 79.59 | |
Ptc Therapeutics I (PTCT) | 2.3 | $25M | 900k | 27.56 | |
Gracell Biotechnologies Sponsored Ads | 2.0 | $22M | 2.2M | 10.04 | |
Revolution Medicines (RVMD) | 1.8 | $20M | 680k | 28.68 | |
Vaxcyte (PCVX) | 1.7 | $19M | 300k | 62.80 | |
Eli Lilly & Co. (LLY) | 1.6 | $18M | 30k | 582.92 | |
New York Community Ban | 1.5 | $16M | 1.6M | 10.23 | |
Intra Cellular Therapies (ITCI) | 1.5 | $16M | 220k | 71.62 | |
Beigene Sponsored Adr (BGNE) | 1.4 | $15M | 85k | 180.36 | |
Avadel Pharmaceuticals Sponsored Adr | 1.4 | $15M | 1.1M | 14.12 | |
Miragen Therapeutics (VRDN) | 1.4 | $15M | 693k | 21.78 | |
Crispr Therapeutics Namen Akt (CRSP) | 1.2 | $14M | 215k | 62.60 | |
Theseus Pharmaceuticals | 1.2 | $13M | 3.3M | 4.05 | |
Atea Pharmaceuticals (AVIR) | 1.1 | $12M | 4.1M | 3.05 | |
Astrazeneca Sponsored Adr (AZN) | 1.1 | $11M | 170k | 67.35 | |
Zymeworks Del (ZYME) | 1.1 | $11M | 1.1M | 10.39 | |
GSK Sponsored Adr (GSK) | 1.0 | $11M | 300k | 37.06 | |
Kiniksa Pharmaceuticals Com Cl A | 1.0 | $11M | 600k | 17.54 | |
Cytomx Therapeutics (CTMX) | 0.9 | $10M | 6.6M | 1.55 | |
Ionis Pharmaceuticals (IONS) | 0.9 | $10M | 200k | 50.59 | |
Beam Therapeutics (BEAM) | 0.9 | $9.5M | 350k | 27.22 | |
Cytokinetics Com New (CYTK) | 0.8 | $9.2M | 110k | 83.49 | |
Ascendis Pharma A/s Sponsored Adr (ASND) | 0.8 | $8.8M | 70k | 125.95 | |
Harmony Biosciences Hldgs In (HRMY) | 0.8 | $8.8M | 271k | 32.30 | |
Cymabay Therapeutics | 0.8 | $8.3M | 350k | 23.62 | |
Iovance Biotherapeutics (IOVA) | 0.8 | $8.1M | 1.0M | 8.13 | |
Cullinan Oncology (CGEM) | 0.7 | $7.9M | 771k | 10.19 | |
Moderna (MRNA) | 0.7 | $7.6M | 77k | 99.45 | |
Rocket Pharmaceuticals (RCKT) | 0.7 | $7.5M | 250k | 29.97 | |
Graphite Bio | 0.6 | $6.5M | 2.5M | 2.62 | |
Bioatla (BCAB) | 0.6 | $6.2M | 2.5M | 2.46 | |
Kinnate Biopharma | 0.6 | $6.2M | 2.6M | 2.37 | |
Adma Biologics (ADMA) | 0.6 | $6.1M | 1.4M | 4.52 | |
Intellia Therapeutics (NTLA) | 0.6 | $6.1M | 200k | 30.49 | |
CVB Financial (CVBF) | 0.6 | $6.1M | 300k | 20.19 | |
Verastem Com New (VSTM) | 0.6 | $6.0M | 742k | 8.14 | |
Biohaven (BHVN) | 0.6 | $6.0M | 140k | 42.80 | |
Equity Comwlth Com Sh Ben Int (EQC) | 0.5 | $5.8M | 300k | 19.20 | |
Esperion Therapeutics (ESPR) | 0.5 | $5.5M | 1.9M | 2.99 | |
Reneo Pharmaceuticals (RPHM) | 0.5 | $5.3M | 3.3M | 1.60 | |
Nuvation Bio Com Cl A (NUVB) | 0.5 | $5.3M | 3.5M | 1.51 | |
Dianthus Therapeutics (DNTH) | 0.5 | $5.2M | 504k | 10.40 | |
Bio Rad Labs Cl A (BIO) | 0.5 | $5.2M | 16k | 322.89 | |
Insmed Com Par $.01 (INSM) | 0.5 | $5.2M | 166k | 30.99 | |
Black Diamond Therapeutics (BDTX) | 0.5 | $5.1M | 1.8M | 2.81 | |
Aurinia Pharmaceuticals (AUPH) | 0.5 | $4.9M | 550k | 8.99 | |
Ventyx Biosciences (VTYX) | 0.5 | $4.9M | 2.0M | 2.47 | |
Veritex Hldgs (VBTX) | 0.5 | $4.9M | 210k | 23.27 | |
BioCryst Pharmaceuticals (BCRX) | 0.4 | $4.8M | 800k | 5.99 | |
Rain Therapeutics | 0.4 | $4.6M | 3.9M | 1.20 | |
Blueprint Medicines (BPMC) | 0.4 | $4.6M | 50k | 92.24 | |
Us Bancorp Del Com New (USB) | 0.4 | $4.3M | 100k | 43.28 | |
Dynavax Technologies Corp Com New (DVAX) | 0.4 | $4.2M | 300k | 13.98 | |
Bolt Biotherapeutics (BOLT) | 0.4 | $4.1M | 3.7M | 1.12 | |
Uniqure Nv SHS (QURE) | 0.4 | $4.1M | 600k | 6.77 | |
Design Therapeutics (DSGN) | 0.4 | $3.9M | 1.5M | 2.65 | |
Cargo Therapeutics (CRGX) | 0.3 | $3.7M | 161k | 23.15 | |
Springworks Therapeutics (SWTX) | 0.3 | $3.7M | 100k | 36.50 | |
Nkarta (NKTX) | 0.3 | $3.6M | 550k | 6.60 | |
Bank of Hawaii Corporation (BOH) | 0.3 | $3.6M | 50k | 72.46 | |
ACADIA Pharmaceuticals (ACAD) | 0.3 | $3.6M | 114k | 31.31 | |
Century Therapeutics (IPSC) | 0.3 | $3.5M | 1.1M | 3.32 | |
Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.3 | $3.5M | 4.4M | 0.79 | |
Cortexyme (QNCX) | 0.3 | $3.4M | 3.2M | 1.05 | |
Arvinas Ord (ARVN) | 0.3 | $3.3M | 80k | 41.16 | |
Karuna Therapeutics Ord | 0.3 | $3.2M | 10k | 316.51 | |
Heron Therapeutics (HRTX) | 0.3 | $3.1M | 1.9M | 1.70 | |
Inflarx Nv (IFRX) | 0.3 | $3.1M | 1.9M | 1.63 | |
Amylyx Pharmaceuticals (AMLX) | 0.3 | $2.9M | 200k | 14.72 | |
Enanta Pharmaceuticals (ENTA) | 0.3 | $2.8M | 300k | 9.41 | |
Athira Pharma (ATHA) | 0.3 | $2.8M | 1.2M | 2.43 | |
Amarin Corp Spons Adr New (AMRN) | 0.2 | $2.7M | 3.1M | 0.87 | |
Fate Therapeutics (FATE) | 0.2 | $2.6M | 700k | 3.74 | |
Seres Therapeutics (MCRB) | 0.2 | $2.5M | 1.8M | 1.40 | |
Passage Bio (PASG) | 0.2 | $2.4M | 2.4M | 1.01 | |
Enzo Biochem (ENZ) | 0.2 | $2.4M | 1.7M | 1.39 | |
Bluebird Bio (BLUE) | 0.2 | $2.3M | 1.7M | 1.38 | |
Silverback Therapeutics (SPRY) | 0.2 | $2.2M | 410k | 5.48 | |
Editas Medicine (EDIT) | 0.2 | $2.0M | 200k | 10.13 | |
Servisfirst Bancshares (SFBS) | 0.2 | $2.0M | 30k | 66.63 | |
Pds Biotechnology Ord (PDSB) | 0.2 | $2.0M | 400k | 4.97 | |
Tango Therapeutics (TNGX) | 0.2 | $2.0M | 200k | 9.90 | |
Elevation Oncology (ELEV) | 0.2 | $2.0M | 3.7M | 0.54 | |
Mei Pharma (MEIP) | 0.2 | $1.9M | 326k | 5.80 | |
Genfit S A Ads (GNFT) | 0.2 | $1.8M | 479k | 3.85 | |
Aclaris Therapeutics (ACRS) | 0.2 | $1.8M | 1.8M | 1.05 | |
Tg Therapeutics (TGTX) | 0.2 | $1.7M | 100k | 17.08 | |
Adicet Bio (ACET) | 0.2 | $1.7M | 876k | 1.89 | |
Aligos Therapeutics (ALGS) | 0.1 | $1.5M | 2.2M | 0.66 | |
Lava Therapeutics Nv SHS (LVTX) | 0.1 | $1.3M | 841k | 1.58 | |
Nektar Therapeutics (NKTR) | 0.1 | $1.3M | 2.3M | 0.56 | |
Alexandria Real Estate Equities (ARE) | 0.1 | $1.3M | 10k | 126.77 | |
Precision Biosciences Ord | 0.1 | $1.2M | 3.4M | 0.36 | |
908 Devices (MASS) | 0.1 | $1.1M | 100k | 11.22 | |
Vanda Pharmaceuticals (VNDA) | 0.1 | $1.0M | 248k | 4.22 | |
Acumen Pharmaceuticals (ABOS) | 0.1 | $948k | 247k | 3.84 | |
Tusimple Hldgs Cl A (TSPH) | 0.1 | $878k | 1.0M | 0.88 | |
Gossamer Bio (GOSS) | 0.1 | $765k | 839k | 0.91 | |
Atyr Pharma Com New (ATYR) | 0.1 | $664k | 471k | 1.41 | |
Syros Pharmaceuticals Com New (SYRS) | 0.1 | $662k | 85k | 7.79 | |
Eagle Pharmaceuticals (EGRX) | 0.1 | $622k | 119k | 5.23 | |
Neuronetics (STIM) | 0.1 | $580k | 200k | 2.90 | |
Stellar Bancorp Ord (STEL) | 0.1 | $557k | 20k | 27.84 | |
Nextcure (NXTC) | 0.0 | $533k | 468k | 1.14 | |
Molecular Partners Ads (MOLN) | 0.0 | $418k | 100k | 4.18 | |
Trevi Therapeutics (TRVI) | 0.0 | $402k | 300k | 1.34 | |
Xeris Pharmaceuticals (XERS) | 0.0 | $353k | 150k | 2.35 | |
Erasca (ERAS) | 0.0 | $320k | 150k | 2.13 | |
Kezar Life Sciences (KZR) | 0.0 | $291k | 307k | 0.95 | |
Equillium (EQ) | 0.0 | $289k | 400k | 0.72 | |
Selecta Biosciences | 0.0 | $276k | 400k | 0.69 | |
Genedx Holdings Corp Com Cl A (WGS) | 0.0 | $175k | 64k | 2.75 | |
Acelrx Pharmaceuticals Com New (TLPH) | 0.0 | $143k | 195k | 0.73 |